FDA NDC Directory · JSON-LD · Markdown

bivalirudin

NDC 70436-025 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Labeler / ManufacturerSlate Run Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213078
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS
Active ingredientsBIVALIRUDIN (250 mg/1)
Marketing started20210630
Package count2

External sources

Source: openFDA. Public-domain (CC0).